LALPATH LAB - Monthly Head and Shoulder Pattern, Rally done now its on Re-test Level, Best pick for short to long term investment.
BUY LEVEL: 3100-3200
STOP LOSS: 2900 on closing Basis (Daily)
TARGET: Mentioned on Chart.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
48.25 INR
3.58 B INR
22.27 B INR
37.14 M
About DR. LAL PATH LABS LTD.
Sector
Industry
CEO
Shankha Banerjee
Website
Headquarters
Gurgaon
Founded
1949
ISIN
INE600L01024
FIGI
BBG009WQGFB4
Dr. Lal PathLabs Ltd. engages in the business of running laboratories for carrying out pathological investigations. It also involves in providing diagnostic and healthcare tests and services. The company was founded by S. K. Lal in 1949 and is headquartered in Gurgaon, India.
LALPATHLAB - End of 4th wave correction?LALPATHLAB - CMP 2957
Price had a one way rally in it's primary 3rd wave from 1945 to 3650
And it is falling at the same speed.
Price convincingly broke the consolidation at the 30% fib around 3000 levels and trading below the same.
50% retracement is at 2800 and AVWAP from the lows is at 2840
LALPATHLAB - EW & Technical Classical 4th wave on Channel Setup CMP: 3095
While combining EW with technical patterns, the general guideline is that
Wave 3 must breakout above the 0-1-2 channel
Wave 4 must take support at the 0-1-2 channel top or at the midpoint
In this chart, price complied both the technical requirements for wave 3 (breakout and runaway)..
the rally is an opportunity to exitDR Lal Path Lab- CMP 2956
A stock that starts with 5 wave correction is just the first wave A of the corrective pattern zig zag. The B wave nearly goes to the start of the wave 3 of A and then the devastating C leg starts. Here the C leg has already started. The correction will be deep. The firs
Lal Path Labs - Sideways stuckStock currently facing resistance at 3400
Current strong support at 3300 / 3230
May remain sideways in the range for quite some time
If premiums remain strong good for strangle or straddle
DYOR - Strictly for study purpose
Reverse head shoulder pattern Reversed from bottom, moving towards all time high.
Seen Reverse head shoulder pattern
Check chart for sp and target.
Dr Lal Path Cmp 3495 Triple Top BO with VolumesDr Lal Path Cmp 3495 dated 4-10-2024
1. Triple Top BO @ 3465 (done)
2. RSI BO
3. Price Rise with Volumes
Buy above 3525 target 3550-3575-3600-3625-3650-3675-3700 SL 3370
It is just a view, please trade at your own risk.
Best stock to buy in this fall-Dr LalpathlabStock has been analyzed based on my trendline analysis. Please note that levels given are for training and educational purpose only. Please do consult your financial advisor before investing in the stock
LALPATHLAB |Upcoming Trade set up|Hey Family, there is a one more stock Which is showing a great opportunity.
Key Points:-
* Formation of Rectangular box Pattern in Daily TF.
* From Aug 2024 to 3 Oct 2024 its in range.
* From Aug 2024 to 3 Oct 2024 Tested & Moving Resistance Many times.
* It's Break resistance Zone and
Dr Lal Pathlabs bullishMoved above all EMA's
Crossed upper bb and made 52 week high with Good volume.
rsi at 67
Macd Positive.
Supertrend indicates buy.
Tgt1 : 3635
Tgt2 : 3750
Only for learning.
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of LALPATHLAB is 3,000.45 INR — it has decreased by −1.31% in the past 24 hours. Watch DR. LAL PATHLABS LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange DR. LAL PATHLABS LIMITED stocks are traded under the ticker LALPATHLAB.
LALPATHLAB stock has risen by 0.69% compared to the previous week, the month change is a 0.01% rise, over the last year DR. LAL PATHLABS LIMITED has showed a 17.32% increase.
We've gathered analysts' opinions on DR. LAL PATHLABS LIMITED future price: according to them, LALPATHLAB price has a max estimate of 3,770.00 INR and a min estimate of 2,461.00 INR. Watch LALPATHLAB chart and read a more detailed DR. LAL PATHLABS LIMITED stock forecast: see what analysts think of DR. LAL PATHLABS LIMITED and suggest that you do with its stocks.
LALPATHLAB reached its all-time high on Sep 15, 2021 with the price of 4,243.00 INR, and its all-time low was 696.50 INR and was reached on Jan 20, 2016. View more price dynamics on LALPATHLAB chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
LALPATHLAB stock is 1.88% volatile and has beta coefficient of 0.61. Track DR. LAL PATHLABS LIMITED stock price on the chart and check out the list of the most volatile stocks — is DR. LAL PATHLABS LIMITED there?
Today DR. LAL PATHLABS LIMITED has the market capitalization of 249.99 B, it has increased by 5.55% over the last week.
Yes, you can track DR. LAL PATHLABS LIMITED financials in yearly and quarterly reports right on TradingView.
DR. LAL PATHLABS LIMITED is going to release the next earnings report on Feb 6, 2025. Keep track of upcoming events with our Earnings Calendar.
LALPATHLAB earnings for the last quarter are 15.50 INR per share, whereas the estimation was 14.85 INR resulting in a 4.38% surprise. The estimated earnings for the next quarter are 11.76 INR per share. See more details about DR. LAL PATHLABS LIMITED earnings.
DR. LAL PATHLABS LIMITED revenue for the last quarter amounts to 6.60 B INR, despite the estimated figure of 6.69 B INR. In the next quarter, revenue is expected to reach 6.00 B INR.
LALPATHLAB net income for the last quarter is 1.29 B INR, while the quarter before that showed 1.06 B INR of net income which accounts for 21.43% change. Track more DR. LAL PATHLABS LIMITED financial stats to get the full picture.
DR. LAL PATHLABS LIMITED dividend yield was 0.80% in 2023, and payout ratio reached 41.82%. The year before the numbers were 0.66% and 41.63% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 15, 2024, the company has 4.10 K employees. See our rating of the largest employees — is DR. LAL PATHLABS LIMITED on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. DR. LAL PATHLABS LIMITED EBITDA is 6.58 B INR, and current EBITDA margin is 27.83%. See more stats in DR. LAL PATHLABS LIMITED financial statements.
Like other stocks, LALPATHLAB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade DR. LAL PATHLABS LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So DR. LAL PATHLABS LIMITED technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating DR. LAL PATHLABS LIMITED stock shows the buy signal. See more of DR. LAL PATHLABS LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.